These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 31511230)

  • 1. Effects of
    Li WQ; Zhang JY; Ma JL; Li ZX; Zhang L; Zhang Y; Guo Y; Zhou T; Li JY; Shen L; Liu WD; Han ZX; Blot WJ; Gail MH; Pan KF; You WC
    BMJ; 2019 Sep; 366():l5016. PubMed ID: 31511230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
    You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
    J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Lifestyle Factors, Vitamin and Garlic Supplementation, and Gastric Cancer Outcomes: A Secondary Analysis of a Randomized Clinical Trial.
    Guo Y; Li ZX; Zhang JY; Ma JL; Zhang L; Zhang Y; Zhou T; Liu WD; Han ZX; Li WQ; Pan KF; You WC
    JAMA Netw Open; 2020 Jun; 3(6):e206628. PubMed ID: 32589229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.
    Ma JL; Zhang L; Brown LM; Li JY; Shen L; Pan KF; Liu WD; Hu Y; Han ZX; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; You WC; Gail MH
    J Natl Cancer Inst; 2012 Mar; 104(6):488-92. PubMed ID: 22271764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.
    Gail MH; You WC; Chang YS; Zhang L; Blot WJ; Brown LM; Groves FD; Heinrich JP; Hu J; Jin ML; Li JY; Liu WD; Ma JL; Mark SD; Rabkin CS; Fraumeni JF; Xu GW
    Control Clin Trials; 1998 Aug; 19(4):352-69. PubMed ID: 9683311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions.
    Gail MH; You WC
    J Nutr; 2006 Mar; 136(3 Suppl):813S-815S. PubMed ID: 16484571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
    Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
    J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer.
    You WC; Zhang L; Gail MH; Ma JL; Chang YS; Blot WJ; Li JY; Zhao CL; Liu WD; Li HQ; Hu YR; Bravo JC; Correa P; Xu GW; Fraumeni JF
    Int J Epidemiol; 1998 Dec; 27(6):941-4. PubMed ID: 10024185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins.
    Zhang L; Gail MH; Wang YQ; Brown LM; Pan KF; Ma JL; Amagase H; You WC; Moslehi R
    Am J Clin Nutr; 2006 Oct; 84(4):912-9. PubMed ID: 17023720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.
    You WC; Chang YS; Heinrich J; Ma JL; Liu WD; Zhang L; Brown LM; Yang CS; Gail MH; Fraumeni JF; Xu GW
    Eur J Cancer Prev; 2001 Jun; 10(3):257-63. PubMed ID: 11432713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term garlic or micronutrient supplementation, but not anti-Helicobacter pylori therapy, increases serum folate or glutathione without affecting serum vitamin B-12 or homocysteine in a rural Chinese population.
    Wang Y; Zhang L; Moslehi R; Ma J; Pan K; Zhou T; Liu W; Brown LM; Hu Y; Pee D; Gail MH; You W
    J Nutr; 2009 Jan; 139(1):106-12. PubMed ID: 19056661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
    Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
    Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
    Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer.
    Xu HM; Han Y; Liu ZC; Yin ZY; Wang MY; Yu C; Ma JL; Sun D; Liu WD; Zhang Y; Zhou T; Zhang JY; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Chen Z; You WC; Li L; Pan KF; Lv J; Li WQ
    JAMA Netw Open; 2024 May; 7(5):e2413708. PubMed ID: 38809553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
    Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
    Choi IJ; Kook MC; Kim YI; Cho SJ; Lee JY; Kim CG; Park B; Nam BH
    N Engl J Med; 2018 Mar; 378(12):1085-1095. PubMed ID: 29562147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
    Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
    J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China.
    Wang GQ; Dawsey SM; Li JY; Taylor PR; Li B; Blot WJ; Weinstein WM; Liu FS; Lewin KJ; Wang H
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):161-6. PubMed ID: 8049638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
    Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
    J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.